Our website use cookies to improve and personalize your experience and to display advertisements (if any). Our website may also include cookies from third parties like Google Adsense, Google Analytics, and Youtube. By using the website, you consent to the use of cookies.

Experts answer questions on vaccines

Experts answer questions on vaccines

BEATRIX LOCKWOOD AN unprecedented COVID-19 vaccine campaign is underway with tens of millions now inoculated in the U.S. and around the world. Dozens of vaccine candidates are still in the pipeline, bringing hope for an end to a global pandemic. As part of our #AskReuters Twitter chat series, Reuters invited a group of healthcare experts to discuss what you should know before getting your shot. Below are edited highlights. How do the various vaccines reduce the risk of COVID-19 and its complications? How long will they provide immunity? "COVID-19 vaccines reduce complications by inducing the immune system to generate antibodies…
Read More
Q&A: Where are we in the COVID-19 vaccine race?

Q&A: Where are we in the COVID-19 vaccine race?

LARGE global trials of several COVID-19 vaccine candidates involving tens of thousands of participants are well underway with some having gathered sufficient data to seek emergency use authorisation. The following is what we know about the race to deliver vaccines to help end the coronavirus pandemic that has claimed more than 1.45 million lives worldwide: Who is furthest along? U.S. drugmaker Pfizer Inc and German partner BioNTech SE released a full late-stage trial data analysis on Nov. 18 that showed their shot was 95% effective at stopping COVID-19, the highest efficacy rate so far. U.S. pharmaceutical company Moderna released its…
Read More